» Articles » PMID: 21049025

The Genetic Influence on the Cortical Processing of Experimental Pain and the Moderating Effect of Pain Status

Overview
Journal PLoS One
Date 2010 Nov 5
PMID 21049025
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Research suggests that the COMT Val(158)Met, BDNF Val(66)Met and OPRM1 A(118)G polymorphisms moderate the experience of pain. In order to obtain experimental confirmation and extension of findings, cortical processing of experimentally-induced pain was used.

Method: A sample of 78 individuals with chronic low back pain complaints and 37 healthy controls underwent EEG registration. Event-Related Potentials were measured in response to electrical nociceptive stimuli and moderation by COMT Val(158)Met, BDNF Val(66)Met and OPRM1 A(118)G polymorphisms was assessed.

Results: Genetic variation did not have a direct effect on cortical processing of experimental pain. However, genetic effects (COMT Val(158)Met and BDNF Val(66)Met) on experimental pain were moderated by the presence of chronic pain. In the presence of chronic pain, the COMT Met allele and the BDNF Met allele augmented cortical pain processing, whilst reducing pain processing in pain-free controls. No significant effects were found concerning the OPRM1 A(118)G polymorphism.

Conclusions: The current study suggests that chronic experience of pain enhances genetic sensitivity to experimentally induced mildly painful stimuli, possibly through a process of epigenetic modification.

Citing Articles

Pain in idiopathic scoliosis not associated with known genetic variants for pain.

Cheng T, Diarbakerli E, Simony A, Andersen M, Danielsson A, Kere J Pain Rep. 2024; 10(1):e1227.

PMID: 39713503 PMC: 11661741. DOI: 10.1097/PR9.0000000000001227.


Brain-Derived Neurotrophic Factor, Nociception, and Pain.

Merighi A Biomolecules. 2024; 14(5).

PMID: 38785946 PMC: 11118093. DOI: 10.3390/biom14050539.


COMT and SCN9A gene variants do not contribute to chronic low back pain in Mexican-Mestizo patients.

Nava-Bringas T, Manrique C, Gonzalez-Huerta N, Morales-Hernandez E, Miranda-Duarte A Acta Neurochir (Wien). 2024; 166(1):73.

PMID: 38329587 DOI: 10.1007/s00701-024-05937-y.


The Role of the Brain-Derived Neurotrophic Factor in Chronic Pain: Links to Central Sensitization and Neuroinflammation.

Xiong H, Hendrix J, Schabrun S, Wyns A, Van Campenhout J, Nijs J Biomolecules. 2024; 14(1).

PMID: 38254671 PMC: 10813479. DOI: 10.3390/biom14010071.


Relationship of cancer-related fatigue with psychoneurophysiological (PNP) symptoms in breast cancer survivors.

Hsiao C, Von Ah D, Chen M, Saligan L Eur J Oncol Nurs. 2023; 68:102469.

PMID: 38039708 PMC: 10922833. DOI: 10.1016/j.ejon.2023.102469.


References
1.
van Os J, Rutten B, Poulton R . Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull. 2008; 34(6):1066-82. PMC: 2632485. DOI: 10.1093/schbul/sbn117. View

2.
Carmon A, Dotan Y, Sarne Y . Correlation of subjective pain experience with cerebral evoked responses to noxious thermal stimulations. Exp Brain Res. 1978; 33(3-4):445-53. DOI: 10.1007/BF00235566. View

3.
Sen S, Duman R, Sanacora G . Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 2008; 64(6):527-32. PMC: 2597158. DOI: 10.1016/j.biopsych.2008.05.005. View

4.
Lotsch J, Stuck B, Hummel T . The human mu-opioid receptor gene polymorphism 118A > G decreases cortical activation in response to specific nociceptive stimulation. Behav Neurosci. 2007; 120(6):1218-24. DOI: 10.1037/0735-7044.120.6.1218. View

5.
van Breukelen G, Van Dijk K . Use of covariates in randomized controlled trials. J Int Neuropsychol Soc. 2007; 13(5):903-4. DOI: 10.1017/s1355617707071147. View